Lilly And Innovent’s Rituximab Gets Chinese Nod

Companies Continue To Collaborate On Oncology Biologics

China - syringe
Eli Lilly and Innovent have partnered on rituximab injection in China • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products